Highlighted products for this procedure

Azurion 7 C12 with FlexVision

Azurion

Compact system design

Lab integration with single touch screen control of IntraSight, hemodynamic monitoring and other Philips' applications

Instant Parallel Working, perform tasks such as 2D-QA during fluoroscopy or exposure

With the Azurion image-guided therapy platform, your medical teams can benefit from a seamless user experience and the simplicity of touch screen control that can improve cath lab workflow. Table side control saves you from going to the control room to access applications. Smart solutions, like ClarityIQ and Zero Dose Positioning, provide efficient dose management. This response helps to support a growing demand for enhanced patient and employee safety.
Azurion 7 C20 with FlexArm

IntraSight interventional applications platform

Philips IntraSight offers you a comprehensive suite of clinically proven imaging, physiology and co-registration10 tools on a modern, secure platform that will help you simplify complex interventions, speed routine procedures and improve lab efficiencies. These best-in-class interventional tools ultimately allow you to go beyond the angiogram and complete your view of the target vessel so you can make fast, informed clinical decisions. IntraSight is built on a modern, scalable platform that will be ready to provide you with new innovations and tools as they become available in the future.
Hemo with IntelliVue X3 workstation

Philips Hemo system with IntelliVue X3 & Xper Information Management

Philips introduces the Interventional Hemodynamic system (Philips Hemo system) which brings advanced hemodynamic measurements to the cath lab. Integrated with the market leading Philips IntelliVue X3 patient monitor, this unique combination enables continuous patient monitoring throughout the cath lab. By connecting the IntelliVue X3 in the cath lab with the Philips Hemo system, you can continuously monitor a patient.

Xper IM is designed to enable more efficient cath lab workflows with hemo monitoring and data management. It streamlines workflows in physician reporting, billing, registry reporting and inventory management.

IntraSight has made an immediate impact in our lab. It’s so simple and intuitive to use that it took us no time at all to get used to it. It has made using physiology and imaging even quicker and easier which is a great advance for us and for our patients.”

Dr. Rasha Al-Lamee

Imperial College London, Hammersmith Hospital

Operational availability icon

135

more hours of operational availability

135 more hours in average of operational availability per year.* Gain time to treat more patients in your interventional suite.

 

* Data shown is in average, based on the comparison between remotely connected and non-remotely connected systems. Data sample from 2018 for Allura FD and Azurion (n=9955)

Improve usability icon

91%

agree that the new touch screen module improves usability

91% of Azurion users think the enhanced touch screen module technology increases the ease of use when switching between compatible applications (e.g., X-ray, iFR/FFR, IVUS, hemo, etc.) during interventions compared to their current system(s).*

 

* Results obtained during a Usability Evaluation in the period of May and June 2019. The tests involved 23 clinicians (16 physicians and 7 technologists) from Europe who performed procedures using Azurion 2.1 image-guided therapy system in a cardiac workflow and non-cardiac workflow in a simulated interventional lab environment.

Cost reduction icon

$ 896

dollars saved
Philips iFR provides $896 cost saving compared to FFR.3

    See clearly. Treat optimally.

    dynamic coronary roadmap

    Dynamic coronary roadmap

     

    A Philips-exclusive technology, creates a motion-compensated, real-time view of coronary arteries. A highlighted coronary angiogram is superimposed on a live 2D fluoroscopic image, creating a colored roadmap that adjusts automatically, providing continuous visual feedback on positioning of wires and catheters.

    StentBoost live

    StentBoost Live
    StentBoost Live10 quickly helps you verify positioning before and after deploying balloons, stents, and intra-coronary devices to display under deployment and confirm full expansion. And it’s all done in real-time, so you no longer need to wait for new images before you reposition.

    IntelliSpace cardiovascular

    IntelliSpace Cardiovascular
    ISCV is designed to streamline workflow throughout the cardiovascular care continuum. Providing a single point of access anytime and virtually anywhere to support informed decision-making. It can be viewed and controlled from the FlexSpot and FlexVision Pro of Azurion, allowing for easy intra-procedural check of pre-operative information.

    Intravascular ultrasound (IVUS) modality

    Intravascular Ultrasound (IVUS)
    Optimize patient outcomes by using a standardized IVUS criteria.1-2  Compared to angiography-guided PCI alone, in all comer patients, ULTIMATE shows that IVUS-guided PCI significantly reduces clinically driven Target Lesion Revascularization (TLR). This benefit was sustained over three years. Only 1.6% TVF* at 12 months and 4.2% TVF at 3 years when optimal IVUS-guided PCI criteria was met.7-13

    iFR (physiology) modality

    iFR modality
    iFR is the leading hyperemia-free physiologic index for measuring pressure in diagnostic and interventional procedures that is recognized by key cardiovascular societies4,5,6,7 Only iFR has clinically validated patient outcome data in the largest physiology studies ever.1,2,3,9 iFR Co-registration maps the physiologic measurements, directly onto the angiogram enabling more complete procedural guidance.
    ELCA coronary laser atherectomy catheter

    ELCA coronary laser atherectomy catheter

    Designed to cross, prepare and treat the most complex coronary lesions. This non-mechanical atherectomy catheter can be delivered over any .014” wire and can de-bulk and modify plaque of multiple morphologies and is approved for the broadest range of coronary indications in atherectomy.
    AngioSculpt

    AngioSculpt RX PTCA scoring balloon catheter

    Significantly alters the landscape for treating CAD, offering the advanced performance that only an innovative clinical solution can provide. The AngioSculpt RX PTCA scoring balloon catheter is the only specialty scoring device indicated for ISR and complex type-C lesions.
    OmniWire pressure guide wire

    OmniWire pressure guide wire

    World’s first solid core pressure guide wire. With an all new workhorse design, only Philips OmniWire pressure guide wire combines confidence in wire performance with proven iFR outcomes and iFR Co-registration, making it easy to benefit from physiology throughout the case.1-3

    Do you want to know more?

    IVUS expert ipad

    Become an IVUS expert


    Advance your IVUS imaging skills with interactive workflows and detailed image interpretation practice. The Philips Coronary IVUS Tutor app is free to download in the App Store or Google Play.
    Cardio app

    Practice using IVUS in cases


    Experience the interactive educational app CardioEx which now features new cases on Philips IVUS, physiology and co-registration. Cardio Ex app is free to download in the App Store or Google Play.
    Twitter image

    Let's talk
    #futureofIGT

    How would you improve coronary procedures?

     

    What do you think about IGT solutions? Are we on the right track? Connect with us via #futureofIGT

    Discover what @PhilipsHealth is sharing

    Go to Twitter and join the conversation

    News and blogs on image-guided therapy

    Disclaimer

    Product availability is subject to country regulatory clearance. Please contact your local sales representative to check the availability in your country.

     

    References

    IntraSight, iFR and OmniWire

    1. Davies JE, et al., DEFINE-FLAIR: A Multi- Centre, Prospective, International, Randomized, Blinded Comparison of Clinical Outcomes and Cost Efficiencies of iFR and FFR Decision-Making for Physiological Guided Coronary Revascularization. New England Journal of Medicine, epub March 18, 2017.
    2. Gotberg M, et al., Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve Guided Intervention (IFR-SWEDEHEART): A Multicenter, Prospective, Registry-Based Randomized Clinical Trial. New England Journal of Medicine, epub March 18, 2017.
    3. Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision-making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.  
    4. Patel M, et al., ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients with Stable Ischemic Heart Disease. J Am Coll Cardiol. 2017 May 2;69(17):2212-2241.
    5. ACC CathPCI Hospital Registry.
    6. Lofti A, et al. Focused update of expert consensus statement: Use of invasive assessments of coronary physiology and structure: A position statement of the society of cardiac angiography and interventions. Catheter Cardiovasc Interv. 2018;1–12.
    7. 2018 ESC/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2018;00:1-96.
    8. An iFR cut-point of 0.89 matches best with an FFR ischemic cut-point of 0.80 with a specificity of 87.8% and sensitivity of 73.0%. (From ADVISE II, and iFR Operator’s Manual 505-0101.23.
    9. Jeremias A et al. The DEFINE PCI Trial: Blinded Physiological Assessment of Residual Ischemia after Successful Angiographic Percutaneous Coronary Intervention, presented at ACC 2019.
    10. Co-registration tools available within IntraSight 7 configuration via SyncVision

     

    IVUS

    * Co-registration tools available within IntraSight 7 configuration via SyncVision

    1. A. Maehara, M. Matsumura, Z.A. Ali, G.S. Mintz, G.W. Stone. IVUS-guided versus OCT-guided coronary stent implantation. J Am Coll Cardiol Img, 10 (2017), pp. 1487- 1503.
    2. Elgendy IY et al. Outcomes with intravascular ultrasound-guided stent implantation: a meta-analysis of randomized trials in the era of drug eluting stents. Circ-Cardiovasc Interv.2016;9:e003700.
    3. Ahn JM, Kang SJ, Yoon SH, et al. Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol. 2014;113:1338-1347. www.ajconline.org/article/S0002-9149(14)00549-9/abstract
    4. ​Witzenbichler B, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: The ADAPT-DES study. Circulation. 2014 Jan:129,4;463-470.
    5. Singh V, Badheka AO, Arora S, et al. Comparison of in-hospital mortality, length of hospitalization, costs, and vascular complications of percutaneous coronary interventions guided by ultrasound versus guided by angiography. Am J Cardiol. Online 18 Feb 2015.
    6. TVF categorized as cardiac death, target vessel MI, and clinical driven TVR.
    7. Zhang J et al. The ULTIMATE trial. Journal of the American College of Cardiology (2018), doi.org/10.1016/j.jacc.2018.09.013. , accepted September 13 2018.
    8. Choi K, et al. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures. JACC: Cardivascular Interventions. Mar 2019, 4281; DOI: 10.1016/j.jcin.2019.01.227.
    9. Levine et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011;124:e574-651].
    10. Kim S, Kim Y, et al. Long-term outcomes of intravascular ultrasound-guided stenting in coronary bifurcation lesions. Am J Cardiol. 2010;106(5):612-8].
    11. Hong, S-J et al. Effect of Intravascular Ultrasound–Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial. JAMA, published online November 10, 2015.
    12. Mariani et al. MOZART study. JACC Interventions 2014; 7:1287-93.
    13. Gao, X. F., Ge, Z., Kong, X. Q., et al. (2021). 3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation. JACC. Cardiovascular interventions, 14(3), 247–257. https://doi.org/10.1016/j.jcin.2020.10.001.

    Contact information

    * This field is mandatory
    *

    Contact details

    *
    *
    *

    Company details

    *
    *
    *

    *

    Contact information

    * This field is mandatory
    *
    *
    *
    *
    *
    *
    *
    *
    *
    By specifying your reason for contact we will be able to provide you with a better service.
    We work with partners and distributors who may contact you about this Philips product on our behalf.
    *
    *

    Philips цени и уважава поверителността на своите клиенти. Можете да оттеглите своите разрешения по всяко време. За повече информация, моля, прочетете Политиката за поверителност на Philips.